X4 Pharmaceuticals, Inc - Chronological SEC Filings

Search Ctrl + K

X4 Pharmaceuticals, Inc

Biological Products, (no Diagnostic Substances)

NASDAQ.XFOR

61 North Beacon Street, 4th Floor, Boston, MA, 02134

- Categorized
- Chronological
- Ownership by Owner
- Insider Transactions
- Institutional Owners
- Filings by Form Type
- Transcripts
- Your Highlights
- Articles & Bylaws
- Indentures
- Material contracts
- Plans of Reorganization
- Underwriting Agreements
- Google Finance
- SEC EDGAR

© 2023 Gheko, Inc. Terms of Service Privacy Policy Browse Companies

Latest Filings – Ownership

Mostafa Adam S.

De Craecker Francoise

Mcgirr David W J

Wyzga Michael S

Latest Filings – Non-Ownership

Quarterly Filing

Results Of Operations And Financial Condition, Financial Statements And Exhibits

Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits

Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.

Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing

Regulation Fd Disclosure

Results Of Operations And Financial Condition, Financial Statements And Exhibits

Quarterly Filing

Regulation Fd Disclosure

Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits

Submission Of Matters To A Vote Of Security Holders

Regulation Fd Disclosure, Financial Statements And Exhibits

Entry Into A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits

Results Of Operations And Financial Condition, Financial Statements And Exhibits

Quarterly Filing

Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.

Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits

Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits

Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.

Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing